ORBIMED ADVISORS LLC - 31 Mar 2025 SCHEDULE 13G Report for Whitehawk Therapeutics, Inc. Common Stock, par value $0.0001 per share (WHWK)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
OrbiMed Advisors LLC
Security
Whitehawk Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
WHWK
Shares outstanding
46,808,989 shares
Disclosed Ownership
4,166,000 shares
Ownership
8.9%
Form type
SCHEDULE 13G
Filing time
15 May 2025, 18:46:15 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"ORBIMED ADVISORS LLC disclosed 8.9% ownership in Whitehawk Therapeutics, Inc. Common Stock, par value $0.0001 per share (WHWK) on 31 Mar 2025."

Quick Takeaways

  • ORBIMED ADVISORS LLC filed SCHEDULE 13G for Whitehawk Therapeutics, Inc. Common Stock, par value $0.0001 per share (WHWK).
  • Disclosed ownership: 8.9%.
  • Date of event: 31 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 May 2025, 18:46.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
OrbiMed Advisors LLC 8.9% 4,166,000 0 4,166,000 /s/ Carl L. Gordon Carl L. Gordon / Member
OrbiMed Genesis GP LLC 8.9% 4,166,000 0 4,166,000 /s/ Carl L. Gordon Carl L. Gordon / Member of OrbiMed Advisors LLC

Sponsored